advisorsecurities master

BNRBurning Rock Biotech Limited American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
12726
Ticker
BNR
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-06-12
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
BNR

Detail

Enriched 2026-08-14 20:47

Market cap
$104,725,185.99
Shares outstanding (class)
8,813,858
Shares outstanding (weighted)
10,546,343
SIC
Employees
667
Location
Description

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data